Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Allergen-specific immunotherapy (desensitization) is a medical intervention aimed at reducing or eliminating allergic responses by retraining the immune system to tolerate specific allergens. This involves controlled exposure to increasing doses of the allergen, leading to immunological changes such as increased IgG4 and regulatory T cell activity, ultimately reducing allergic reactions upon natural exposure.
Induction of tolerance through repeated controlled exposure to allergens, leading to increased IgG4 and Treg activity, and decreased IgE and Th2 activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Desensitization via Allergen-Specific Immunotherapy) (N/A).